Skip to main content
logo
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
211.38
-0.20 (-0.09%)
At close: Aug 25, 2026, 4:00 PM EDT
211.75
+0.37 (0.18%)
Pre-market: Aug 26, 2026, 7:33 AM EDT

Revolution Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
45,30615,3988,0834,7202,1151,855
Market Cap Growth
554.87%90.50%71.26%123.15%14.03%-29.43%
Enterprise Value
42,55913,8816,6203,9691,5251,278
Last Close Price
211.3879.6543.7428.6823.8225.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---407.5859.7863.11
PB Ratio
17.389.443.572.583.093.08
P/TBV Ratio
17.879.873.682.693.463.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---342.7843.1143.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.460.260.060.050.090.11
Net Debt / Equity Ratio
-1.05-0.98-0.95-0.97-0.85-0.85
Net Debt / EBITDA Ratio
1.701.363.153.752.282.76
Net Debt / FCF Ratio
2.231.753.794.932.473.32
Asset Turnover
---0.010.050.05
Quick Ratio
11.126.9813.9712.8910.489.66
Current Ratio
11.387.1514.2013.0610.659.77
Return on Equity (ROE)
-79.09%-58.07%-29.33%-34.75%-38.63%-34.73%
Return on Assets (ROA)
-30.12%-30.08%-18.66%-20.71%-20.83%-18.00%
Return on Capital Employed (ROCE)
-41.00%-57.30%-28.80%-24.80%-34.40%-27.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.90%-7.35%-7.42%-9.25%-11.76%-10.09%
FCF Yield
-2.72%-5.93%-7.02%-7.59%-11.12%-8.29%
Buyback Yield / Dilution
-10.45%-13.35%-48.24%-40.34%-10.74%-32.68%
SEC Filings: 10-K · 10-Q